Drug Delivery Disposition and Dynamics
Other research themes
Our latest news
Victorian Government Treasurer, Tim Pallas, recently visited the Monash Technology Precinct at the University’s Clayton campus where he met with the scientists behind the MMIC, an initiative dedicated to strengthening sovereign medicines
MIPS will be home to two researchers awarded close to $1M in funding through the ARC Discovery Early Career Researcher Award scheme.
Three outstanding mid-career researchers and new ARC Future Fellows, Associate Professor Darren Creek, Dr Nicholas Veldhuis and Dr Roey Elnathan have received close to $3M in funding to advance research projects addressing a range of medical needs.
A new study led by Monash University researchers has, for the first time, shown that the chemical compound 'nitroxyl' may represent an effective and rapid intervention for cardiovascular emergencies in type 2 diabetes.
Monash University is delighted that Moderna will be joining other world-leading research and technology companies in the Monash Technology Precinct, under an agreement signed with the Victorian government.
A collaborative team of Melbourne researchers from Monash University and the University of Melbourne have received $5.4 million from the Victorian government to establish The Victorian mRNA Innovation Hub to develop next-generation mRNA vaccines and
Nanotechnology researchers from Monash University have published an article in the high impact journal, Nature Nanotechnology, highlighting the opportunities and challenges involved in commercialising nanoneedle technology for sensing and clinical
The Travelling Award will provide Dr Cao with the unique opportunity to travel to Colorado, USA, to attend the Keystone Symposium – Adipose tissue: energising good fat.
A drug delivery platform developed by Monash University researchers in partnership with PureTech Health plc has shown for the first time in humans that a drug that currently must be injected due to breakdown in the liver after oral administration,